Inventor · disambiguated record
Bart Barlogie
Also filed as: BARLOGIE BART
18 granted patents·15 pending applications·176 citations·filing 2002–2024
93Inventor score
Files withSHAUGHNESSY JR JOHN D11BIOVENTURES LLC8UNIV ARKANSAS8SHAUGHNESSY JOHN D5UNIV ARKANSAS MED SCIENCES1
Top patents by PatentIndex Score
33 records- 0195US7308364B2Diagnosis of multiple myeloma on gene expression profilingUNIV ARKANSAS MED SCIENCES·Filed 2003·Granted Dec 11, 2007·112 cites·2 claims
- 0292US8843320B2Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JOHN D·Filed 2005·Granted Sep 23, 2014·14 cites·6 claims
- 0391US7935679B2Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myelomaUNIV ARKANSAS·Filed 2005·Granted May 3, 2011·11 cites·4 claims
- 0490US7741035B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2005·Granted Jun 22, 2010·9 cites·4 claims
- 0589US7983850B2Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2008·Granted Jul 19, 2011·6 cites·9 claims
- 0684US7668659B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2002·Granted Feb 23, 2010·12 cites·4 claims
- 0782US8954283B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JR JOHN D·Filed 2009·Granted Feb 10, 2015·4 cites·4 claims
- 0881US9650677B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2013·Granted May 16, 2017·1 cites·7 claims
- 0979US2025084485A1Gep5 model for multiple myelomaBIOVENTURES LLC·Filed 2024·Application pending·0 cites
- 1078US7894992B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2003·Granted Feb 22, 2011·5 cites·4 claims
- 1173US2020270691A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 1270US8124087B2Methods of controlling bone loss by inhibiting DKK1SHAUGHNESSY JR JOHN D·Filed 2008·Granted Feb 28, 2012·1 cites·7 claims
- 1368US10597729B2Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2017·Granted Mar 24, 2020·0 cites·8 claims
- 1468US2020291486A1Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 1567US12060618B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2020·Granted Aug 13, 2024·0 cites·15 claims
- 1667US8992909B2Methods of increasing bone mass in a subject comprising inhibiting DKK1SHAUGHNESSY JR JOHN D·Filed 2012·Granted Mar 31, 2015·1 cites·3 claims
- 1763US2008234139A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 1862US10577656B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2017·Granted Mar 3, 2020·0 cites·17 claims
- 1962US9714451B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Jul 25, 2017·0 cites·4 claims
- 2062US9574238B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Feb 21, 2017·0 cites·13 claims
- 2161US10752956B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2017·Granted Aug 25, 2020·0 cites·9 claims
- 2259US2011319470A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2011·Application pending·0 cites
- 2358US9822419B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2014·Granted Nov 21, 2017·0 cites·31 claims
- 2455US2008234138A1TP53 gene expression and uses thereofSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 2554US2008280779A1Gene expression profiling based identification of genomic signatures of multiple myeloma and uses thereofSHAUGHNESSY JR JOHN D·Filed 2007·Application pending·0 cites
- 2652US2008187930A1Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereofSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 2751US2010152136A1TP53 Gene expression and uses thereofSHAUGHNESSY JR JOHN D·Filed 2009·Application pending·0 cites
- 2845US2013209446A1Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic TargetsSHAUGHNESSY JR JOHN D·Filed 2011·Application pending·0 cites
- 2943US2013059746A1Gene expression profiling of cytogenetic abnormalitiesSHAUGHNESSY JR JOHN D·Filed 2012·Application pending·0 cites
- 3042US2015140016A1Molecular Determinants of Myeloma Bone Disease and Uses ThereofSHAUGHNESSY JR JOHN D·Filed 2015·Application pending·0 cites
- 3138US2012015906A1Uses of bortezomib in predicting survival in multiple myeloma patientsSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
- 3236US2012269802A1Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression ProfilingSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
- 3335US2010316629A1Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bart Barlogie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →